Skip to main content

Table 3 Characteristics of substance use among HCV antibody positive and negative PWID

From: Prevalence of and risk factors for hepatitis C virus antibody among people who inject drugs in Cambodia: a national biological and behavioral survey

Substance use characteristics

Total (n = 286)

HCV antibody test result

Positive (n = 87)

Negative (n = 199)

n (%)

n (%)

n (%)

P valuea

Median months using drugs (IQR)

49 (16–120)

96 (36–132)

36 (12–120)

< 0.001

Mode of first drug use—injecting

104 (50.3)

51 (58.6)

93 (46.7)

0.06

Injecting drugs in the past 3 months

250 (88.0)

84 (96.6)

166 (84.3)

0.003

Type of drugs most commonly used in the past 3 months

 Heroin

156 (61.9)

67 (79.8)

89 (53.0)

< 0.001

 Yama/ice (methamphetamine)

60 (23.8)

21 (25.0)

39 (23.2)

0.75

 Ecstasy

9 (3.6)

0 (0.0)

9 (5.4)

0.27

Always used new syringes/needles in the past 3 months

112 (66.7)

27 (61.4)

85 (68.5)

0.54

Used needles/syringes used by someone else in the past 3 months

37 (21.6)

8 (18.2)

29 (22.8)

0.31

Having been sent to a drug rehabilitation center in the past 12 months

119 (41.6)

55 (63.2)

64 (32.2)

< 0.001

Having received methadone maintenance therapy in the past 12 months

125 (43.7)

68 (78.2)

57 (28.6)

< 0.001

Alcohol drinking ≥ 3 times per week

84 (29.4)

13 (14.9)

71 (35.7)

< 0.001

Binge drinking ≥ 3times per week (n = 171)

83 (48.5)

13 (36.1)

70 (51.9)

0.09

  1. HCV hepatitis C virus, IQR interquartile range, PWID people who inject drugs
  2. aChi-square (or Fisher’s exact test when a cell count was smaller than 5) was used for categorical variables and Mann-Whitney U test for continuous variables